United States · FDA National Drug Code directory
OMEPRAZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-688_1ac7526d-c24f-66d3-e063-6294a90a42d1
- Product NDC
- 71610-688
- Form
- CAPSULE, DELAYED RELEASE PELLETS
- Composition / generic term
- OMEPRAZOLE
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170703
- Source listing expiry
- 20261231
Source-listed ingredients
- OMEPRAZOLE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-30) · 71610-688-30
- 1300 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-43) · 71610-688-43
- 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-53) · 71610-688-53
- 650 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-58) · 71610-688-58
- 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-60) · 71610-688-60
- 180 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-80) · 71610-688-80
- 2400 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (71610-688-87) · 71610-688-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →